Jing Ning
Jing Ning
The University of Texas MD Anderson Cancer Center
Dirección de correo verificada de mdanderson.org
Título
Citado por
Citado por
Año
Complete surgical excision is essential for the management of patients with breast implant–associated anaplastic large-cell lymphoma
MW Clemens, LJ Medeiros, CE Butler, KK Hunt, MA Fanale, S Horwitz, ...
Journal of Clinical Oncology 34 (2), 160, 2016
2532016
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study.
Cancer Discov., 2018
113*2018
Analyzing length-biased data with semiparametric transformation and accelerated failure time models
Y Shen, J Ning, J Qin
Journal of the American Statistical Association 104 (487), 1192-1202, 2009
1052009
Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery
B Badgwell, J Stanley, GJ Chang, MHG Katz, HY Lin, J Ning, SV Klimberg, ...
Journal of surgical oncology 108 (3), 182-186, 2013
932013
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
P Jayaprakash, M Ai, A Liu, P Budhani, T Bartkowiak, J Sheng, C Ager, ...
The Journal of clinical investigation 128 (11), 5137-5149, 2018
732018
Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
GN Tamamyan, HM Kantarjian, J Ning, P Jain, K Sasaki, KL McClain, ...
Cancer 122 (18), 2857-2866, 2016
612016
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
P Williams, S Basu, G Garcia‐Manero, CS Hourigan, KA Oetjen, ...
Cancer 125 (9), 1470-1481, 2019
592019
Maximum likelihood estimations and EM algorithms with length-biased data
J Qin, J Ning, H Liu, Y Shen
Journal of the American Statistical Association 106 (496), 1434-1449, 2011
542011
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
K Takahashi, N Pemmaraju, P Strati, G Nogueras-Gonzalez, J Ning, ...
Blood 122 (16), 2807-2811, 2013
502013
Phase IB/II study of nivolumab in combination with azacytidine (AZA) in patients (pts) with relapsed acute myeloid leukemia (AML)
N Daver, S Basu, G Garcia-Manero, JE Cortes, F Ravandi, EJ Jabbour, ...
Blood, The Journal of the American Society of Hematology 128 (22), 763-763, 2016
482016
Website usage and weight loss in a free commercial online weight loss program: retrospective cohort study
KO Hwang, J Ning, AW Trickey, CN Sciamanna
Journal of medical Internet research 15 (1), e11, 2013
482013
Using short‐term response information to facilitate adaptive randomization for survival clinical trials
X Huang, J Ning, Y Li, E Estey, JP Issa, DA Berry
Statistics in medicine 28 (12), 1680-1689, 2009
482009
Immunohistochemical expression of hormone receptors in melanoma of pregnant women, non-pregnant women and men
JH Zhou, KB Kim, JN Myers, PS Fox, J Ning, RL Bassett, H Hasanein, ...
The American Journal of Dermatopathology 36 (1), 74, 2014
372014
Response‐adaptive randomization for clinical trials with adjustment for covariate imbalance
J Ning, X Huang
Statistics in medicine 29 (17), 1761-1768, 2010
352010
Nonparametric estimation of bivariate failure time associations in the presence of a competing risk
K Bandeen-Roche, J Ning
Biometrika 95 (1), 221-232, 2008
352008
Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma
MT Tetzlaff, RR Singh, EG Seviour, JL Curry, CW Hudgens, D Bell, ...
The Journal of pathology 240 (1), 84-95, 2016
322016
Buckley–James‐type estimator with right‐censored and length‐biased data
J Ning, J Qin, Y Shen
Biometrics 67 (4), 1369-1378, 2011
312011
A Bayesian dose-finding design for drug combination trials with delayed toxicities
S Liu, J Ning
Bayesian analysis 8 (3), 703, 2013
302013
高考成绩与大学成绩的相关性研究
宁静, 肖婕, 缪柏其, 戴小莉, 宋昌耐
高等理科教育, 46-50, 2001
292001
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
blood, 2018
26*2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20